These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 31771160)
21. Design of a Broad-Range Bacteriophage Cocktail That Reduces Pseudomonas aeruginosa Biofilms and Treats Acute Infections in Two Animal Models. Forti F; Roach DR; Cafora M; Pasini ME; Horner DS; Fiscarelli EV; Rossitto M; Cariani L; Briani F; Debarbieux L; Ghisotti D Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555626 [TBL] [Abstract][Full Text] [Related]
22. Phage ΦPan70, a Putative Temperate Phage, Controls Pseudomonas aeruginosa in Planktonic, Biofilm and Burn Mouse Model Assays. Holguín AV; Rangel G; Clavijo V; Prada C; Mantilla M; Gomez MC; Kutter E; Taylor C; Fineran PC; Barrios AF; Vives MJ Viruses; 2015 Aug; 7(8):4602-23. PubMed ID: 26274971 [TBL] [Abstract][Full Text] [Related]
23. Phage phiKZ-The First of Giants. Krylov V; Bourkaltseva M; Pleteneva E; Shaburova O; Krylov S; Karaulov A; Zhavoronok S; Svitich O; Zverev V Viruses; 2021 Jan; 13(2):. PubMed ID: 33498475 [TBL] [Abstract][Full Text] [Related]
24. Pseudomonas aeruginosa bacteriophage PA1Ø requires type IV pili for infection and shows broad bactericidal and biofilm removal activities. Kim S; Rahman M; Seol SY; Yoon SS; Kim J Appl Environ Microbiol; 2012 Sep; 78(17):6380-5. PubMed ID: 22752161 [TBL] [Abstract][Full Text] [Related]
25. Predation in homogeneous and heterogeneous phage environments affects virulence determinants of Pseudomonas aeruginosa. Hosseinidoust Z; Tufenkji N; van de Ven TG Appl Environ Microbiol; 2013 May; 79(9):2862-71. PubMed ID: 23435883 [TBL] [Abstract][Full Text] [Related]
26. P. aeruginosa flow-cell biofilms are enhanced by repeated phage treatments but can be eradicated by phage-ciprofloxacin combination. Henriksen K; Rørbo N; Rybtke ML; Martinet MG; Tolker-Nielsen T; Høiby N; Middelboe M; Ciofu O Pathog Dis; 2019 Mar; 77(2):. PubMed ID: 30821815 [TBL] [Abstract][Full Text] [Related]
27. Resistance against two lytic phage variants attenuates virulence and antibiotic resistance in García-Cruz JC; Rebollar-Juarez X; Limones-Martinez A; Santos-Lopez CS; Toya S; Maeda T; Ceapă CD; Blasco L; Tomás M; Díaz-Velásquez CE; Vaca-Paniagua F; Díaz-Guerrero M; Cazares D; Cazares A; Hernández-Durán M; López-Jácome LE; Franco-Cendejas R; Husain FM; Khan A; Arshad M; Morales-Espinosa R; Fernández-Presas AM; Cadet F; Wood TK; García-Contreras R Front Cell Infect Microbiol; 2023; 13():1280265. PubMed ID: 38298921 [TBL] [Abstract][Full Text] [Related]
28. A proposed integrated approach for the preclinical evaluation of phage therapy in Pseudomonas infections. Danis-Wlodarczyk K; Vandenheuvel D; Jang HB; Briers Y; Olszak T; Arabski M; Wasik S; Drabik M; Higgins G; Tyrrell J; Harvey BJ; Noben JP; Lavigne R; Drulis-Kawa Z Sci Rep; 2016 Jun; 6():28115. PubMed ID: 27301427 [TBL] [Abstract][Full Text] [Related]
29. Characterization of Pseudomonas lytic phages and their application as a cocktail with antibiotics in controlling Pseudomonas aeruginosa. Ong SP; Azam AH; Sasahara T; Miyanaga K; Tanji Y J Biosci Bioeng; 2020 Jun; 129(6):693-699. PubMed ID: 32107153 [TBL] [Abstract][Full Text] [Related]
30. Introducing differential RNA-seq mapping to track the early infection phase for Wicke L; Ponath F; Coppens L; Gerovac M; Lavigne R; Vogel J RNA Biol; 2021 Aug; 18(8):1099-1110. PubMed ID: 33103565 [TBL] [Abstract][Full Text] [Related]
31. Characterisation of broad-spectrum phiKZ like jumbo phage and its utilisation in controlling multidrug-resistant Pseudomonas aeruginosa isolates. Rai P; Shetty SS; Prabell S; Kuntar A; Pinto D; Kumar BK; Divyashree M; Raj JRM; Premanath R; Deekshit VK; Karunasagar I; Karunasagar I Microb Pathog; 2022 Nov; 172():105767. PubMed ID: 36096457 [TBL] [Abstract][Full Text] [Related]
33. The Pseudomonas aeruginosa generalized transducing phage phiPA3 is a new member of the phiKZ-like group of 'jumbo' phages, and infects model laboratory strains and clinical isolates from cystic fibrosis patients. Monson R; Foulds I; Foweraker J; Welch M; Salmond GPC Microbiology (Reading); 2011 Mar; 157(Pt 3):859-867. PubMed ID: 21163841 [TBL] [Abstract][Full Text] [Related]